Another Piece of Evidence for Early Administration of Biologics in Children with Crohn's Disease Who Start as an Inflammatory Phenotype

참고문헌 (8)

1. Jin Soo Moon, "Clinical aspects and treatments for pediatric inflammatory bowel diseases", Intestinal research, 17(1), pp.17~23 (2019), 대한장연구학회[DOI]
2. Turner D, "STRIDE-II : an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease(STRIDE)Initiative of the International Organization for the Study of IBD(IOIBD) : determining therapeutic goals for treat-to-target strategies in IBD", Gastroenterology, 160, pp.1570~1583 (2021)
3. Kerur B, "Biologics delay progression of Crohn's disease, but not early surgery, in children", Clin Gastroenterol Hepatol, 16, pp.1467~1473 (2018)
4. Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]
5. Kim Hyun Jin, "Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea", Gut and Liver, 15(6), pp.851~857 (2021), 거트앤리버 소화기연관학회협의회[DOI]
6. Dulai PS, "Should we divide Crohn's disease into ileum-dominant and isolated colonic diseases?", Clin Gastroenterol Hepatol, 17, pp.2634~2643 (2019)
7. Kenji Watanabe, "Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion", Intestinal research, 18(4), pp.347~354 (2020), 대한장연구학회[DOI]
8. Levine A, "Pediatric modification of the Montreal classification for inflammatory bowel disease : the Paris classification", Inflamm Bowel Dis, 17, pp.1314~1321 (2011)

관련 논문AI추천